Showing results (861-870 of 932) with videos related to
Sort By:
Pageof 94
Antiviral Research|January 1, 1997
Assessment of pain in herpes zoster: lessons learned from antiviral trialsR H Dworkin, D Carrington, A Cunningham, et al.Journal of Neurovirology|July 23, 2005
Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblastsScott A Simpson, Michael D Manchak, Elizabeth J Hager, et al.Journal of Clinical Microbiology|October 7, 2005
Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central AmericaCarlos Ponce, Elisa Ponce, Elizabeth Vinelli, et al.Current Eye Research|February 1, 2021
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year PeriodMaitri Pancholy, Philip P Storey, Hannah J Levin, et al.The Lancet. Infectious Diseases|April 11, 2016
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trialChan R Beals, Radha A Railkar, Andrea K Schaeffer, et al.Journal of the American Geriatrics Society|September 25, 2010
Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adultsKenneth E Schmader, Gary R Johnson, Patricia Saddier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.The Journal of Infectious Diseases|October 11, 2015
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older AdultsMyron J Levin, Kenneth E Schmader, Lei Pang, et al.Southern Medical Journal|June 14, 2014
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)Joann M Schulte, Abbie R Bellamy, Edward W Hook, et al.Nature|April 8, 2011
Crystal structure of a phosphorylation-coupled saccharide transporterYu Cao, Xiangshu Jin, Elena J Levin, et al.Pageof 94